Valens Groworks — Valens Company — Investor Day (February 2022)
75 slides from Valens Groworks's investor day presentation, Feb 8, 2022
Slide 1: Investor Day 2022
TSX: VLNS NASDAQ:VLNS INVESTOR DAY 2022 THEVALENSCOMPANY.COM
Slide 2: Notice to Recipient and Forward-Looking Statements
NOTICE TO RECIPIENT This presentation (the “Presentation”) of The Valens Company Inc.(the “Company” or “The Valens Company” or “Valens”) is an overview only and does not contain all the information that a prospective investor may require to make investment decisions. This Presentation is for informa
Slide 3: Cautionary Notes and Third Party Information
Historical statements contained in this Presentation regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. In this regard, certain financial information contained herein has been extracted from, or based upon, informat
Slide 4: Investor Day Video
TSX: VLNS NASDAQ:VLNS INVESTOR DAY VIDEO
Slide 5: Opening Remarks: Valens Leadership Team
OPENING REMARKS VALENS LEADERSHIP TEAM 5 TSX: VLNS | NASDAQ: VLNS Tyler Robson, B.A.& Sc. Chair of the Board, Chief Executive Officer & Co-founder Mr. Robson has worked extensively over the last decade in cannabis science, focusing on R&D, proprietary extraction processing and medical application. U
Slide 6: Table of Contents
6 TABLE OF CONTENTS 1. Opening Remarks 2. Long Term Market Opportunity 3. 2021 Review and Recap 4. 2022 Business Plan 5. Summary and Closing Remark
Slide 7: Tyler Robson, Chief Executive Officer & Chairman
T Y L E R ROBSON CHIEF EXECUTIVE OFFICER & CHAIRMAN
Slide 8: Opening Remarks: Key Objectives for 2022
OPENING REMARKS KEY OBJECTIVES FOR 2022 8 TSX: VLNS | NASDAQ: VLNS 8 TSX: VLNS | NASDAQ: VLNS Rolling out revenue and EBITDA guidance for 2023: 1. Successfully transitioned the business into a leading Provincial Sales platform with quickly growing brands 2. Deployed “Fewer, Bigger, Better” approach
Slide 9: Our Mission: Bringing the Benefits of Cannabis to the World
OUR MISSION BRINGING THE BENEFITS OF CANNABIS TO THE WORLD 9 TSX: VLNS | NASDAQ: VLNS
Slide 10: Opening Remarks: Key Themes for 2022
OPENING REMARKS KEY THEMES FOR 2022 Canadian Market Landscape Contract Grow Supports Flexible Platform Innovation • Entering a transitional year • Expect continued decrease in biomass pricing through 2022 • Increased consolidation in 2022 will open up market share opportunities • Contract grow is ke
Slide 11: Everett Knight, EVP Corporate Development & Capital Markets
EVERETT KNIGHT EVP CORPORATE DEVELOPMENT & CAPITAL MARKETS
Slide 12: Key Stats Snapshot and Capital Markets Fundamentals
12 TSX: VLNS | NASDAQ: VLNS (1) Hifyre data for Ontario, Alberta, British Columbia and Saskatchewan for the three months ended January 2022 vs the year-ago period (2) BDSA September 2021 Cannabis Forecast; converted at USD/CAD exchange rate of 1.24 (3) S&P Capital IQ as of January 31, 2022, Consensu
Slide 13: Capitalizing on the Global Legalization of Cannabis
LONG TERM MARKET OPPORTUNITY CAPITALIZING ON THE GLOBAL LEGALIZATION OF CANNABIS 13 (1) BDSA September 2021 Cannabis Forecast; converted at USD/CAD exchange rate of 1.24 Estimated Size of Global Legal Cannabis Market(1) • The global legal cannabis market is expected to reach C$77.0 billion in 2026,
Slide 14: Cannabis Market Forecasts
LONG TERM MARKET OPPORTUNITY CANNABIS MARKET FORECASTS 14 TSX: VLNS | NASDAQ: VLNS $1.2 $2.6 $3.9 $5.0 $10.0 2019 2020 2021 2022 LEGAL + ILLICIT CANADIAN CANNABIS MARKET FORECAST (C$B) 1 2 +156% 1 $22.3 $30.9 $37.2 $58.9 2020 2021 2022 2023 2024 2025 2026 U.S. CANNABIS MARKET FORECAST (C$B)(3) +91%
Slide 15: Cannabis Is a Top Four Consumer Category in the U.S.
$146.0 $119.3 $98.8 $82.1 $81.2 $67.3 $29.0 $26.5 $22.2 $21.9 $19.4 $19.3 $17.2 $3.9 LONG TERM MARKET OPPORTUNITY CANNABIS IS A TOP FOUR CONSUMER CATEGORY IN THE U.S. 15 (1) Euromonitor, BDSA, Jefferies Estimates; Jefferies Initiation Report on US Cannabis dated July 7, 2021, Market opportunity for
Slide 16: Underperformance of Growth Stocks in the Back Half of 2021
LONG TERM MARKET OPPORTUNITY 16 • Cannabis companies faced a challenging 2021 with the most pain felt in less liquid, small-mid capitalization companies • Despite having the lowest enterprise value of the top Canadian LPs, Valens outperformed half of its peer group • In general, growth stocks experi
Slide 17: Valuation Multiples
LONG TERM MARKET OPPORTUNITY VALUATION MULTIPLES 17 TSX: VLNS | NASDAQ: VLNS • Valens trades at a significant discount of 1.0x EV/Revenue 2022E compared to its US Listed Canadian LP peers at 3.6x • Valens also trades at a significant discount compared to mature CPG industries (tobacco, pharmaceutica
Slide 18: Institutional Ownership
LONG TERM MARKET OPPORTUNITY INSTITUTIONAL OWNERSHIP 18 TSX: VLNS | NASDAQ: VLNS • Valens recently listed on the Nasdaq and anticipates a catch-up in institutional adoption versus its Nasdaq listed LP peers • Institutional ownership in the sector is ~44% lower than the average of mature CPG industri
Slide 19: Growth Rates of Canada vs U.S.
LONG TERM MARKET OPPORTUNITY GROWTH RATES OF CANADA VS U.S. 19 TSX: VLNS | NASDAQ: VLNS 12.5% 4.0% 3.3% 1.3% -1.8% -5.2% -5.5% -10.8% -19.2% Growth Rates (Jun-Nov 2021)(1) • Canada has grown 12.5% in the 6-months from June to November 2021, growing faster than all U.S. states with over $100 million
Slide 20: Canadian Market Landscape
LONG TERM MARKET OPPORTUNITY CANADIAN MARKET LANDSCAPE • There are currently over 800 companies competing in the Canadian cannabis marketplace today • Valens anticipates that there will be bankruptcies and with it opportunities to take market share in 2022 • Valens is competing in strategic categori
Slide 21: Clear Identity: Valens Differentiators
1. One of the most innovative manufacturing platforms in Canada Fully built and comprehensive manufacturing and distribution platform which utilizes the latest forms of innovation and automation 2. Strategically positioned downstream from cultivation Use of contract growing partners combined with sp
Slide 22: 2021 Review & Recap
TSX: VLNS NASDAQ:VLNS 2021 REVIEW & RECAP
Slide 23: Delivering on Commitments
23 TSX: VLNS | NASDAQ: VLNS DELIVERING ON COMMITMENTS EXITED 2021 AS A COMPLETELY DIFFERENT COMPANY THAN WHEN VALENS ENTERED Expanded Domestic & Global Footprint: Began Trading on NASDAQ: Corporate Visibility Liquidity Shareholder Base 8 Provinces & Territories 50 States 10 Countries Entered US Mark
Slide 24: Valens in the Value Chain
CORE OPERATIONS RECENTLY ADDED OPERATIONS CULTIVATION EXTRACTION / BIOMASS SOURCING PURIFICATION FORMULATION PRODUCT MANUFACTURING BRANDED PRODUCTS SALES & DISTRIBUTION One of the largest buyers of biomass in Canada The only LP in Canada with a full suite of extraction capabilities Scale and efficie
Slide 25: B2B Sales - Fewer, Bigger, Better
2021 REVIEW & RECAP B2B SALES - FEWER, BIGGER, BETTER 25 TSX: VLNS | NASDAQ: VLNS 2 1 3 4 5 Increase productivity and improve asset utilization Provide services from manufacturing to sales and distribution Simplify relationships with “Fewer, Bigger, Better” strategy Provide platform for CPG branding
Slide 26: Provincial Sales - Demonstrated Sales Execution
2021 REVIEW & RECAP PROVINCIAL SALES - DEMONSTRATED SALES EXECUTION ACROSS INDUSTRY LEADING PRODUCTS 26 TSX: VLNS | NASDAQ: VLNS Provincial Listings Province Q1 2021 Q4 2021 Jan 2022 ON 22 52 57 AB 22 56 62 BC 18 35 38 SK 13 27 33 MB 0 33 33 Other 0 16 32 Total Listings 75 219 255 Total Provincially
Slide 27: Largest Growth in Retail Sales Among Peers
2021 REVIEW & RECAP LARGEST GROWTH IN RETAIL SALES AMONG PEERS 27 TSX: VLNS | NASDAQ: VLNS • Valens had the largest Y/Y growth in retail sales among peers in its largest provincial markets • 374% sales growth Y/Y • 40% sales growth Q/Q • Strong progress demonstrates Valens’ clear execution ability a
Slide 28: One of the Largest Players in Ontario
2021 REVIEW & RECAP ONE OF THE LARGEST PLAYERS IN ONTARIO – CANADA’S LARGEST MARKET 28 TSX: VLNS | NASDAQ: VLNS • Valens has demonstrated success in Ontario, Canada’s largest market, achieving the 8th highest market share of OCS depletions in January 2022 • Strong momentum in January 2022 with the l
Slide 29: Awarded Top Extraction Company: Brands Review
AWARDED TOP EXTRACTION COMPANY Green Roads 2021 REVIEW & RECAP 29 TSX: VLNS | NASDAQ: VLNS Citizen Stash Verse LYF Food Technology • One of the oldest and most trusted brands in the US CBD industry 200,000+ Customers currently opted- in to Green Road’s email list 7,000 Retail locations • Strategic e
Slide 30: Chantel Popoff, Chief Operating Officer
CHANTEL POPOFF CHIEF OPERATING OFFICER
Slide 31: Operations: Significant Milestones Despite a Challenging Environment
OPERATIONS: 2021 REVIEW & RECAP SIGNIFICANT MILESTONES DESPITE A CHALLENGING ENVIRONMENT 31 TSX: VLNS | NASDAQ: VLNS ✓ Enables Valens to leverage its low-cost cannabis platform to drive product sales ✓ Launched flower, pre-rolls, and topicals as new product verticals in 2021 ✓ Doubled vape manufactu
Slide 32: Best in Class Product Innovation
OPERATIONS: BEST IN CLASS PRODUCT INNOVATION ONE OF THE MOST INNOVATIVE & DIVERSIFIED MANUFACTURING PLATFORMS IN CANADA 32 TSX: VLNS | NASDAQ: VLNS JANUARY 2021 JANUARY 2022 • Distillate, Full Spectrum • 1g format • SoRSE emulsion: water soluble, quick onset, no taste/smell, shelf stable • 355 ml PE
Slide 33: Demonstrated Execution Abilities in Record Year
OPERATIONS: 2021 REVIEW & RECAP DEMONSTRATED EXECUTION ABILITIES IN RECORD YEAR 33 • 2021 was an increasingly complex environment for Valens operations team, not only as order flow ramped up significantly but also due to heightened lead times and costs stemming from the pandemic TSX: VLNS | NASDAQ:
Slide 34: Exiting 2021 with the Best Positioned Asset Base
OPERATIONS: 2021 REVIEW & RECAP EXITING 2021 WITH THE BEST POSITIONED ASSET BASE 34 • One of the premier manufacturing platforms for cannabis in the world, right sized for the current state of the market • Large investments have been made into automation equipment and best practices which help drive
Slide 35: Adam Shea, Chief Commercial Officer
A D A M S H E A CHIEF COMMERCIAL OFFICER
Slide 36: Key Objectives for Canadian Provincial Sales and B2B
2022 BUSINESS PLAN KEY OBJECTIVES FOR CANADIAN PROVINCIAL SALES AND B2B • Successful transition to branded product sales and finished goods manufacturing for B2B customers from toll processing and strictly B2B in 18 months Key objectives for 2022: 1. Vapes, Edibles, Beverages - Top 5 player 2. Flowe
Slide 37: Listings in Every Major Category Across Price Points
BY THE END OF 2022, VALENS EXPECTS TO HAVE LISTINGS IN EVERY MAJOR CATEGORY ACROSS ALL THREE MAJOR PRICE POINTS THIS PORTFOLIO WILL RUN ACROSS FOUR KEY BRANDS: VERSUS, CITIZEN STASH, CONTRABAND & VACAY MORE BRANDS ARE EXPECTED TO BE ADDED IN 2023 & 2024 TO SATISFY THE WIDE VARIETY OF CONSUMER TASTES
Slide 38: Covering the Market with a Tight Set of Brands
2022 BUSINESS PLAN COVERING THE MARKET WITH A TIGHT SET OF BRANDS 38 TSX: VLNS | NASDAQ: VLNS FLOWER PRE-ROLL VAPE CONCENTRATES EDIBLES BEVERAGES PREMIUM CORE VALUE VERSUS IS OUR VALUE PLAY ACROSS ALL MAJOR CATEGORIES & WILL BE THE OVERALL VOLUME & REVENUE LEADER FOR VALENS CITIZEN STASH IS EXPECTED
Slide 39: Valens House of Brands
2022 BUSINESS PLAN VALENS HOUSE OF BRANDS 39 TSX: VLNS | NASDAQ: VLNS
Slide 40: Provincial Sales - Cross Canada Penetration
40 2022 BUSINESS PLAN PROVINCIAL SALES - CROSS CANADA PENETRATION S H I N Y B UD • Increasing retail relationships through regulated trade activity and budtender education to drive product awareness • Current exposure to 80%+ of the Canadian market and actively working for a solution to its footprin
Slide 41: B2B Sales - Focus on Fewer, Bigger, Better
2022 BUSINESS PLAN B2B SALES - FOCUS ON FEWER, BIGGER, BETTER 41 TSX: VLNS | NASDAQ: VLNS Legacy B2B Business Working with many LPs and Brand Partners • Lack of consistency in order volumes • Higher quantity of customer touch points • Smaller order quantities • Disadvantaged by long term consolidati
Slide 42: End to End Solution Provider for Large Scale CPG
2022 BUSINESS PLAN END TO END SOLUTION PROVIDER FOR LARGE SCALE CPG TSX: VLNS | OTCQX: VLNCF 42 Testing & R&D Commercialization Product Launch • OTC CBD sales will likely be permitted in Canada, much the like U.S., opening the door for a significant increase in distribution • Valens has been working
Slide 43: Quinn Shiskin, Director Product Innovation
Q U I N N SHISKIN DIRECTOR PRODUCT INNOVATION
Slide 44: The Secret Sauce - Valens Is an Innovation Machine
44 2022 BUSINESS PLAN THE SECRET SAUCE - VALENS IS AN INNOVATION MACHINE 44 TSX: VLNS | NASDAQ: VLNS EXTENSIVE MANUFACTURING ASSETS & TECHNOLOGY DEEP CANNABIS FORMULATION + CPG PRODUCT DEVELOPMENT EXPERTISE LOWEST COST EXTRACTION & BIOMASS SOURCING • CO2, Ethanol, Hydrocarbon Extraction • Automated
Slide 45: Selection of 2022 Targeted Innovation
2022 BUSINESS PLAN SELECTION OF 2022 TARGETED INNOVATION 45 TSX: VLNS | NASDAQ: VLNS FLOWER PRE-ROLL VAPE CONCENTRATES EDIBLES BEVERAGES PREMIUM • Flap Jacks 3.5g • Flap Jacks 7g • Platinum Cookies 3.5g • Platinum Cookies 7g • Oreoz 3.5g • Oreoz 7g • 1 x 1g CNDYLND • 1 x 1g Flap Jacks • 1 x 1g Plati
Slide 46: Innovation Spotlight - Infused Pre-Rolls
46% 54% Infused Pre-Rolls Non-Infused Pre-Rolls 2022 BUSINESS PLAN INNOVATION SPOTLIGHT - INFUSED PRE-ROLLS 46 TSX: VLNS | NASDAQ: VLNS • As consumers look for new and innovative products in the market, infused pre-rolls are anticipated to gain market share in Canada • An infused pre-roll is manufac
Slide 47: Innovation Spotlight - SoRSE Emulsion Technology
2022 BUSINESS PLAN INNOVATION SPOTLIGHT - SORSE EMULSION TECHNOLOGY 47 TSX: VLNS | NASDAQ: VLNS FAILED EMULSION EMULSIONS ARE NOT CREATED EQUALLY • Proven stability of emulsion • Low sensory impact (cannabis taste free) • Repeatable experience SōRSE BY VALENS - PROVEN STABILITY • No creaming, clarif
Slide 48: Jeff Fallows, President
JEFF FALLOWS P R E S I D E N T
Slide 49: U.S. CBD Market Poised for Growth
2022 BUSINESS PLAN U.S. CBD MARKET POSIED FOR GROWTH 49 • The U.S. CBD market presents a compelling opportunity • Significant revenue growth potential • Strong gross margins (50%+) • Strategic entry into the U.S. ahead of regulatory changes that can create a demand explosion • Increased access to in
Slide 50: The Green Roads Brand Is Strong and Well Positioned
2022 BUSINESS PLAN THE GREEN ROADS BRAND IS STRONG AND WELL POSITIONED 50 $565 $415 $172 $168 $140 $121 $0 $100 $200 $300 $400 $500 $600 Sales Per $MM ACV of the Top 5 Brands(1) Green Roads has one of the highest sales per retailer where the brand is sold TSX: VLNS | NASDAQ: VLNS Aware : Consider Aw
Slide 51: Green Roads Strategic Initiatives
Initiative Rationale 1. Maximize the strength of the Green Roads brand ✓ Solution-based products simplify the consumer buy decision and allow us to interact with them every day 2. Distribution channel review and alignment ✓ Market has shifted and so has where consumers look for CBD-based health and
Slide 52: Selling Solutions
2022 BUSINESS PLAN SELLING SOLUTIONS – IT’S MORE THAN JUST SELLING CBD … SO MUCH MORE 52 TSX: VLNS | NASDAQ: VLNS We believe you can do more than just “get through” the day. We believe you can OWN it. And we’re here to help
Slide 53: Three Pathways to Market - Retail, Online and White Label
2022 BUSINESS PLAN THREE PATHWAYS TO MARKET – RETAIL, ONLINE AND WHITE LABEL 53 • Opportunities for significant growth are available in each path • Growth drivers differ and require considerable operational efficiency and coordination across the business • Contribution is expected to change as the o
Slide 54: Retail Strategy - Brick-and-Mortar Locations
2022 BUSINESS PLAN RETAIL STRATEGY – BRICK-AND-MORTAR LOCATIONS 54 1. Strategies must be channel specific – one size does not fit all • Target the channels that best position our Solutions • Align products, formats and pricing strategies • Experienced salespeople paired with strategic broker relatio
Slide 55: Retail Strategy - Online D2C
2022 BUSINESS PLAN RETAIL STRATEGY – ONLINE D2C 55 1. Green Roads first ever brand campaign launched in January 2022 –“Own The Day” 2. Online strategy was synchronized with the launch • Search, affiliate, email, social, programmatic bidding 3. Strategies designed to attract consumers at all levels o
Slide 56: Sunil Gandhi, Chief Financial Officer
S U N I L GANDHI CHIEF FINANCIAL OFFICER
Slide 57: Revenue Segmentation
2022 BUSINESS PLAN REVENUE SEGMENTATION 57 TSX: VLNS | NASDAQ: VLNS Provincial Sales 40 - 50% Green Roads / International 25 - 35% B2B 15 - 25% Other 2 - 5% 5 of the top 7 Canadian LPs PARTNER BRANDS Retail/B2C Segments TM
Slide 58: Cost Synergies and Optimization
58 TSX: VLNS | NASDAQ: VLNS 2022 BUSINESS PLAN COST SYNERGIES AND OPTIMIZATION 2021 was a highly transformational year for Valens including the integration of strategic acquisitions: The next phases of our ‘Launch, Grow, Optimize’ strategy are well underway after a highly successful ‘Launch’ phase t
Slide 59: Initial $10MM of Cost Efficiencies Identified
2022 BUSINESS PLAN INITIAL $10MM OF COST EFFICIENCIES IDENTIFIED 59 We are now capturing the first wave of synergies through operational and organizational changes that will not only improve our efficiencies but also drive the business towards becoming EBITDA positive in fiscal Q4 2022 TSX: VLNS | N
Slide 60: M&A Integration Progress
60 2022 BUSINESS PLAN M&A INTEGRATION PROGRESS FINANCIAL SYSTEMS OPERATIONS COMMERCIAL COMMENTS • Successfully licensed and commissioned • Supply chain, regulatory and quality processes in place • ERP implementation complete • Operating at high capacity • Successful launch of numerous new products,
Slide 61: Cost Efficiencies Through Optimized Biomass Sourcing
2022 BUSINESS PLAN COST EFFICIENCIES THROUGH OPTIMIZED BIOMASS SOURCING 61 TSX: VLNS | NASDAQ: VLNS • Valens is unique relative to other Canadian licensed producers in that it doesn’t own or operate material cultivation operations, instead choosing to source biomass from a diversified network of gro
Slide 62: Cost Efficiencies Through Enhanced Automation & Process Improvement
2022 BUSINESS PLAN COST EFFICIENCIES THROUGH ENHANCED AUTOMATION & PROCESS IMPROVEMENT 62 • During 2021, Valens was focused on launching new products in the various provinces which was initially supported by largely manual processes • In 2022, the focus has shifted to automation & standardized proce
Slide 63: Improving Management of Working Capital
100% 120% 140% 160% 180% 200% 220% Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Accounts Receivables Inventory 2022 BUSINESS PLAN IMPROVING MANAGEMENT OF WORKING CAPITAL 63 TSX: VLNS | NASDAQ: VLNS • Valens expects to see a gradual decline in its accounts receivables as a % of revenue throughout 2022 • Recei
Slide 64: Major Capital Projects Completed, Capex to Normalize
2022 BUSINESS PLAN MAJOR CAPITAL PROJECTS COMPLETED, ANNUAL RATES OF EXPENDITURE TO NORMALIZE 64 • Valens has invested heavily into its world class facilities and is well positioned to take advantage of its buildout • Remaining expenditures in 2022 and 2023 relate to automation equipment to drive ef
Slide 65: The Pathway to Profitability and Positive Cash Flow
2022 BUSINESS PLAN THE PATHWAY TO PROFITABILITY AND POSITIVE CASH FLOW 65 TSX: VLNS | NASDAQ: VLNS Expected Cadence of Financial Results Q1/22 Q2/22 Q3/22 Q4/22 Net Revenue Gross Profit EBITDA • Valens expects to achieve positive EBITDA in Q4/22 through strong revenue growth and sustainable margin e
Slide 66: Jeff Fallows, President
JEFF FALLOWS P R E S I D E N T
Slide 67: Valens Has Been Focused on Driving Shareholder Value
0% 20% 40% 60% 80% 100% 120% 140% VLNS LP 1 LP 2 LP 3 LP 4 LP 5 LP 6 LP 7 LP 8 2022 BUSINESS PLAN VALENS HAS BEEN FOCUSED ON DRIVING SHAREHOLDER VALUE 67 Cannabis Revenue per Dollar Invested(1) Investing in the right assets and opportunities drives long term shareholder value TSX: VLNS | NASDAQ: VLN
Slide 68: Understanding the Valuation Gap
68 EV (C$MM)(1) EV / 2022E Revenue(1) Dual Listing US Exposure Portfolio of Brands Exposure to Full Canadian TAM Pathway to Profitability $180 1.0x $4,182 4.8x $3,770 6.2x $1,085 4.2x $607 2.3x $501 3.4x $405 2.7x TSX: VLNS | NASDAQ: VLNS UNDERSTANDING THE VALUATION GAP FACTORS LEADING TO THE VALUAT
Slide 69: Positioned to Close the Valuation Gap
2022 BUSINESS PLAN POSITIONED TO CLOSE THE VALUATION GAP 69 TSX: VLNS | NASDAQ: VLNS Valens trades at 1.0x EV / 2022E Revenue compared to average cannabis peers at 3.6x(1) The Valuation Gap 1. Fundamentals focused: Short-term voting machine, long-term weighing machine 2. Revenue growth: as provincia
Slide 70: Tyler Robson, Chief Executive Officer & Chairman
T Y L E R ROBSON CHIEF EXECUTIVE OFFICER & CHAIRMAN
Slide 71: Summary & Conclusion
SUMMARY & CONCLUSION 71 TSX: VLNS | NASDAQ: VLNS
Slide 72: Questions and Comments
72 TSX: VLNS | NASDAQ: VLNS QUESTIONS AND COMMENTS
Slide 73: Appendix A: Sector Cohorts
APPENDIX A 73 TSX: VLNS | NASDAQ: VLNS SECTOR COHARTS Category Soft Drink Coca-Cola Beer AB Inbev Tobacco Philip Morris International Cannabis Curaleaf Coffee Starbucks Wine Constellation Spirits Diageo Brands Digital Entertainment Comcast Craft Beer Boston Beer Chocolate Mondelez International Bott
Slide 74: Appendix B: Industry Constituents
APPENDIX B 74 TSX: VLNS | NASDAQ: VLNS INDUSTRY CONSTITUENTS US Listed Canadian LPs Technology Packaged Foods Non-US Listed Canadian LPs Tilray Brands, Inc. Netflix, Inc. Conagra Brands, Inc. Auxly Cannabis Group Inc. Canopy Growth Corporation Shopify Inc. B&G Foods, Inc. Rubison Organics Inc. Auror
Slide 75: Contact Us
CONTACT US TORONTO KELOWNA 96 Spadina Ave, Suite 400 Toronto, ON 230 Carion Rd Kelowna, BC EMAIL PHONE IR@TheValensCompany.com 1 647-956-8254 TSX: VLNS | NASDAQ: VLNS 75